Platinum,diamminedichloro-, (SP-4-1)- cas no:14913-33-8
Synonyms: trans-Platinumdiammine dichloride;Platinum,diamminedichloro-, trans- (8CI);NSC 131558;Transplatin;trans-DDP;trans-Diaminedichloroplatinum;trans-Diamminedichloroplatinum;trans-Diamminedichloroplatinum(II);trans-Dichlorodiamineplatinum(II);trans-Dichlorodiammine platinum;trans-Dichlorodiammineplatinum(II);trans-Platinum(II) ammonium chloride;
NamePlatinum,diamminedichloro-, (SP-4-1)-
CAS14913-33-8
Synonymstrans-Platinumdiammine dichloride;Platinum,diamminedichloro-, trans- (8CI);NSC 131558;Transplatin;trans-DDP;trans-Diaminedichloroplatinum;trans-Diamminedichloroplatinum;trans-Diamminedichloroplatinum(II);trans-Dichlorodiamineplatinum(II);trans-Dichlorodiammine platinum;trans-Dichlorodiammineplatinum(II);trans-Platinum(II) ammonium chloride;
EINECS(EC#)238-980-9
Molecular FormulaCl2H6N2Pt
Molecular Weight300.05
AppearanceYellow Powder or Crystal
refractive index1.706
storage tempStore in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Globally Harmonized System of Classification adn Labelling of Chemicals(GHS)
Hazardclass6.1(a)
Hazard T:Toxic;
Risk R23/24/25;R40;R42/43;R68
Safety
Poison by intraperitoneal route. Questionable carcinogen with experimental tumorigenic data. Human mutation data reported. See also PLATINUM COMPOUNDS. When heated to decomposition it emits toxic fumes of NOx and Cl−.Safety information of trans-Dichlorodiammineplatinum(ii) (CAS NO.14913-33-8):
Hazard Codes 
T,
Xn
Risk Statements
45 May cause cancer
68 Possible risk of irreversible effects
42/43 May cause sensitization by inhalation and skin contact
23/24/25 Toxic by inhalation, in contact with skin and if swallowed
Safety Statements
53 Avoid exposure - obtain special instruction before use
36/37/39 Wear suitable protective clothing, gloves and eye/face protection
RIDADR UN 3288 6.1/PG 2
WGK Germany 3
RTECS TP2455000
F 10-21
HazardClass 6.1(a)
PackingGroup II
| 1. |
|
mma-sat 2 µg/plate
|
|
MUREAV Mutation Research. 77 (1980),45. |
| 2. |
|
dnd-hmn:fbr 50 µmol/L/4H
|
|
CNREA8 Cancer Research. 42 (1982),145. |
| 3. |
|
dnd-hmn:lng 100 µmol/L
|
|
CBINA8 Chemico-Biological Interactions. 36 (1981),345. |
| 4. |
|
dnd-hmn:oth 20 mg/L
|
|
CNREA8 Cancer Research. 45 (1985),6232. |
| 5. |
|
msc-ham:lng 100 mg/L
|
|
CNREA8 Cancer Research. 44 (1984),3270. |
| 6. |
|
ipr-mus LD50:27 mg/kg
|
|
CBINA8 Chemico-Biological Interactions. 5 (1972),415. |
